Skip to content
  • Prescribing Information
  • Medication Guide
  • Important Safety Information
Sodium Oxybate Oral Solution Logo
  • ABOUT
  • HOW TO GET
  • HOW TO USE
  • SAVINGS PROGRAM
  • FAQ
  • FOR PRESCRIBERS
Previous

30-Dollar-Asset_SOOSCoral

By admin|2022-12-12T15:50:07+00:00December 12th, 2022|Comments Off on 30-Dollar-Asset_SOOSCoral

Share This Story, Choose Your Platform!

FacebookXRedditLinkedInTumblrPinterestVkEmail

About the Author: admin

Privacy Policy Terms of Use Legal Notices About Hikma

Customer Service: Phone 800.631.2174 | Email
© Hikma Pharmaceuticals USA Inc. All rights reserved.
XYREM® is a registered trademark of Jazz Pharmaceuticals plc.
Hikma
This website uses cookies and third party services. Please see our cookie policy and privacy policy for more information. Ok
READ MORE...

Important Safety Information for Sodium Oxybate Oral Solution

WARNING: Taking Sodium Oxybate Oral Solution with other Central Nervous System (CNS) depressants such as medicines used to make you or your child fall asleep, including opioid analgesics, benzodiazepines, sedating antidepressants, antipsychotics, sedating anti-epileptic medicines, general anesthetics, muscle relaxants, alcohol, or street drugs, may cause serious medical problems, including trouble breathing (respiratory depression), low blood pressure (hypotension), changes in alertness (drowsiness), fainting (syncope), and death.

WARNING: CENTRAL NERVOUS SYSTEM DEPRESSION and ABUSE AND MISUSE

•  Central Nervous System Depression
Sodium Oxybate Oral Solution is a Central Nervous System (CNS) depressant. In clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in adult patients treated with Sodium Oxybate Oral Solution. Many patients who received Sodium Oxybate Oral Solution during clinical trials in narcolepsy were receiving CNS stimulants.